On Thursday 2 March, the European Union and the United States reached agreement on mutual recognition of manufacturers of medicines for human beings.
Regulators have agreed to recognise inspections of manufacturing sites for human medicines conducted by the EU member states’ authorities and the Food and Drug Administration (FDA) in the US. Inspections on either side of the Atlantic will be limited to exceptional circumstances in the future. The agreement will not affect the approval...